Healthcare -
Biotechnology - NASDAQ - US
$ 4.725
-3.77 %
$ 214 M
Market Cap
-7.05
P/E
YMAB - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity YMAB - Y-mAbs Therapeutics, Inc.
120 M
LAST VALUE
-7.93%
2 YEAR CAGR
-11.14%
5 YEAR CAGR
0.00%
10 YEAR CAGR